Our F & D Department is dedicated towards development of New Dosage form for the present Generic molecules which would enhance its Pharmacokinetic profile and Bioavailability.

Formulation Development includes:

• Preformulation studies
• General Screening of Formulations
• Pilot batch studies

Presently Company is working on variety of dosage forms including immediate release (IR), controlled release (CR) modified release (MR), extended release (ER), solid oral, oral thin films (OTF), oral dispersible tablets (ODT), sublingual, injections, patches and suspensions.

Also future plans are to develop various other Novel Drug Delivery System (NDDS) with collaboration with the innovators of the drug molecule.

We perform following studies:

Stability & B.A/B.E Study:
Protocols for Stability Studies and Bio-Availability Studies / Bio-Equivalence Studies are designed and the said studies are done with tie ups.

Analytical Method Development / Validation:
In process and finished products analytical methods and quality control methods are developed and validated.

Process Development / Validation:
Manufacturing process including various stages of the drug manufacturing with in process quality control checks are developed and validated. And the same is scaled up from pilot batch to scale up batch size after validation studies.